"Swiss Visio a pour mission de garantir une qualité supérieure autant dans le diagnostic, que dans le traitement et l’accompagnement de patients atteints de pathologies oculaires telles que: glaucome, cataractes, etc"

During the past decade, SwissVisio Montchoisi conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "SwissVisio Montchoisi" #1 collaborator was "Manchester Royal Eye Hospital" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "SwissVisio Montchoisi" are "Glaucoma Capsulare" (1 trials), "Glaucoma Congenital" (1 trials), "Glaucoma Eye" (1 trials), "Glaucoma Open-Angle" (1 trials) and "Glaucoma Secondary" (1 trials). Many other conditions were trialed in "SwissVisio Montchoisi" in a lesser frequency.

Most popular intervention types in "SwissVisio Montchoisi" are "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "eyeWatch" (1 trials). Other intervention names were less common.

The vast majority of trials in "SwissVisio Montchoisi" are 2 trials for "All" genders.

Currently, there are NaN active trials in "SwissVisio Montchoisi". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were undefined completed trials in SwissVisio Montchoisi, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in SwissVisio Montchoisi, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".